NASDAQ Composite opens in less than twelve hours and Arena Pharmaceuticals’s premarket value is already 1.67% down.
The last session, NASDAQ Composite finished with Arena Pharmaceuticals rising 1.71% to $78.31. NASDAQ Composite jumped 0.43% to $13,128.95, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session.
Arena Pharmaceuticals’s last close was $78.31, 15.17% below its 52-week high of $90.19.
Arena Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.71%, 0.48%, and 0.59%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 7.15%, 4.71%, and 3.72%, respectively.